StockNews.AISignal intelligence
Company intelligence

SYM

Symbotic Inc. · NASDAQ · Financial Services

Price$36.82+5.08% · +$1.78
Market cap22.29BEquity value
P / E44.4Trailing ratio
Volume1.18MLatest session
Market data

SYM price chart

TradingView
Related signals
1 min delayed

Browse public SYM signals with their source context and measured market impact. Open any signal for its permanent analysis page.

SYMOct 29, 2026+1.42% since signal

Symbotic Secures Expanded Walmart Deal Worth About $6 Billion

Symbotic announced a significant expansion of its Walmart agreement, with the retailer committing about $6 billion over several years to deploy more supply-chain automation across its distribution network. The deal boosts revenue visibility and reinforces Walmart's ongoing automation push, potentially expanding Symbotic's backlog and scale advantages, while execution risk and customer concentration remain considerations.

View signal analysis
SYMDec 4, 2025-4.92% since signal

Symbotic Stock Tanks 15%. Why Walmart’s Partner Is Falling.

Symbotic stock fell 15% to $62.38 due to a public offering. 10 million shares offered, diluting current investor holdings significantly. The company's volatility is marked by a 90-day beta of 4.1. Symbotic's relationship with Walmart remains crucial for strategic growth. Analysts express concern over customer concentration after recent revenue fluctuations.

View signal analysis
SYMNov 26, 2025+3.74% since signal

Is Symbotic Beating Competitors?

SYM's stock doubled over the last year, outperforming GGG and GHM. Stock surged 40% after Medline deal, reducing dependency on Walmart. Persistent profitability challenges with a negative P/E ratio. Revenue growth at 35.7% indicates strong demand for AI automation. Investment focus on R&D contributed to lowest operating margin among peers.

View signal analysis
SYMNov 25, 2025+12.95% since signal

This $46 billion robotics stock is up nearly 40% after a big win. Could more gains be in store?

Symbotic signed Medline as its first healthcare customer, diversifying revenue sources. Stock surged 39.4%, marking the largest one-day gain since November 2023. Revenue of $618 million surpassed expectations, reporting only a 3 cent loss per share. Merging into healthcare may reduce reliance on Walmart, which accounts for 85% revenue. Analysts raised price targets, indicating potential for further stock price increase.

View signal analysis
SYMNov 25, 2025+15.07% since signal

Symbotic Analysts Increase Their Forecasts After Q4 Earnings

Symbotic exceeded Q4 revenue expectations at $618.46 million. Reported losses of three cents per share met analyst estimates. First quarter fiscal 2026 revenue projected between $610-$630 million. Analysts raised price targets post-earnings, indicating strong support. Symbotic shares rose 35.8% following the earnings announcement.

View signal analysis
Research

Company intelligence